Notably, the MSA-mediated inhibitory growth effect on ES tumors persisted beyond the treatment period and tumor growth delay was accompanied by increased FOXO1 protein levels (Figures 6g and h), suggesting a potent anti-tumorigenic activity of MSA. The gene discussed is FOXO1; the disease is neoplasm.